Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06507072 · ClinicalTrials.gov registry record · NA
Adaptive Rock Climbing
A NA study of Congenital Upper Limb Differences, sponsored by Children's Hospital Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06507072 is a NA study of Congenital Upper Limb Differences that is actively recruiting participants, run by Children's Hospital Los Angeles. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06507072, a NA study of Congenital Upper Limb Differences, is actively recruiting participants, sponsored by Children's Hospital Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to assess changes in functional and psychosocial outcomes following a 12-week adaptive rock-climbing program for children with congenital upper limb differences. The main questions it aims to answer are * Assess functional outcomes following a 12-week adaptive rock-climbing program. * Assess psychosocial outcomes following a 12-week adaptive rock climbing program. * Assess barriers to participation in adaptive sports. Participants will complete 12-week adaptive rock climbing program.
Conditions Studied
Interventions
- BEHAVIORAL Adaptive Rock Climbing Program
Study Locations (1)
California
- Children Hospital Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-12-06 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06507072
The ClinicalTrials.gov registry entry for NCT06507072 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital Upper Limb Differences appearing as the primary indexed condition, and to 1 intervention - of which Adaptive Rock Climbing Program is the first listed.
NCT06507072 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06507072 about?
NCT06507072 is a clinical study titled "Adaptive Rock Climbing". The goal of this clinical trial is to assess changes in functional and psychosocial outcomes following a 12-week adaptive rock-climbing program for children with congenital upper limb differences. The main questions it aims to answer are * Assess functional outcomes following a 12-week adaptive roc...
What is the current status of trial NCT06507072?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-12-06. Estimated completion is 2026-05-31.
What conditions does trial NCT06507072 study?
This clinical trial studies the following conditions: Congenital Upper Limb Differences.
What interventions are being tested in trial NCT06507072?
The interventions under investigation include: Adaptive Rock Climbing Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06507072?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06507072 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.